Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

PODXL anticorps (AA 100-200)

PODXL Reactivité: Humain WB, FACS Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN540335
  • Antigène Voir toutes PODXL Anticorps
    PODXL (Podocalyxin-Like (PODXL))
    Épitope
    • 16
    • 13
    • 12
    • 5
    • 5
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 100-200
    Reactivité
    • 81
    • 23
    • 14
    • 8
    • 1
    • 1
    Humain
    Hôte
    • 51
    • 40
    • 1
    Lapin
    Clonalité
    • 52
    • 40
    Polyclonal
    Conjugué
    • 44
    • 8
    • 8
    • 5
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp PODXL est non-conjugé
    Application
    • 66
    • 32
    • 29
    • 27
    • 22
    • 20
    • 10
    • 9
    • 7
    • 5
    • 4
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), Flow Cytometry (FACS)
    Fonction
    Rabbit polyclonal antibody raised against synthetic peptide of PODXL.
     Réactivité croisée
    Humain
    Attributs du produit
    Antibody Reactive Against Synthetic Peptide.
    Immunogène
    A synthetic peptide corresponding to amino acids 100-200 of human PODXL.
    Top Product
    Discover our top product PODXL Anticorps primaire
  • Indications d'application
    Flow Cytometry (1:100)
    Western Blot (2 μg/mL)
    The optimal working dilution should be determined by the end user.
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    In Tris-glycine, 150 mM NaCl (0.05 % sodium azide)
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C,-80 °C
    Stockage commentaire
    Store at -20°C or -80°C.
    Aliquot to avoid repeated freezing and thawing.
  • Casey, Neville, Liu, Plummer, Cicek, Krumroy, Curran, McGreevy, Catalona, Klein, Witte: "Podocalyxin variants and risk of prostate cancer and tumor aggressiveness." dans: Human molecular genetics, Vol. 15, Issue 5, pp. 735-41, (2006) (PubMed).

    Kelley, Huntsman, McNagny, Roskelley, Hsi: "Podocalyxin: a marker of blasts in acute leukemia." dans: American journal of clinical pathology, Vol. 124, Issue 1, pp. 134-42, (2005) (PubMed).

    Somasiri, Nielsen, Makretsov, McCoy, Prentice, Gilks, Chia, Gelmon, Kershaw, Huntsman, McNagny, Roskelley: "Overexpression of the anti-adhesin podocalyxin is an independent predictor of breast cancer progression." dans: Cancer research, Vol. 64, Issue 15, pp. 5068-73, (2004) (PubMed).

  • Antigène
    PODXL (Podocalyxin-Like (PODXL))
    Autre désignation
    Podocalyxin / PODXL (PODXL Produits)
    Synonymes
    anticorps Gp200, anticorps PC, anticorps PCLP, anticorps PCLP-1, anticorps PCB, anticorps AW121214, anticorps Ly102, anticorps Pclp1, anticorps podocalyxin, anticorps MEP21, anticorps PODXL, anticorps Gp135, anticorps PCLP1, anticorps cPCLP1, anticorps podxl, anticorps fc18d02, anticorps wu:fc18d02, anticorps Pc, anticorps Pcb, anticorps Podxl, anticorps podocalyxin like, anticorps pyruvate carboxylase, anticorps podocalyxin-like, anticorps PODXL, anticorps PC, anticorps Podxl, anticorps podxl, anticorps Pcx
    ID gène
    5420
    Pathways
    Tube Formation
Vous êtes ici:
Support technique